Investment News

The Royal Women’s Hospital Joins CLEO Ovarian Cancer Trial

Cleo Diagnostics (COV:AU) has announced The Royal Women’s Hospital Joins CLEO Ovarian Cancer Trial

Download the PDF here.

This post appeared first on investingnews.com

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *